Skip to main content

Advertisement

SpringerLink
Log in

Management of gout by Moroccan rheumatologists: a Moroccan Society for Rheumatology National Survey

  • Recommendations
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

To assess the modalities and current practices in gout management reported by Moroccan rheumatologists. We performed a cross-sectional online survey using a questionnaire e-mailed to 360 rheumatologists included 30 multiple-choice questions. 105 rheumatologists responded to the survey with 29% of response rate. The number of gout patients seen per month was five (3–9); they were referred in 58.7% by a general practitioner. The clinical presentation of gout patients was dominated by gout crisis in 71%, and the association gout crisis and gouty arthropathy accounted for 19% of severe forms. 40% of rheumatologists apply the 2015ACR/EULAR classification criteria. Obesity accounted for 85.7% of the associated comorbidities. The most commonly prescribed Urate-lowering therapy (ULT) was allopurinol in 81.3% (± 12). 48% of rheumatologists reported starting allopurinol at 200 mg daily and associated it with colchicine during the first 6 months by 33.3%. The determination of uric acid levels was monitoring in 76.2% every 3 months. Administration of ULT to asymptomatic hyperuricemia was found in 69.5% when patients had renal complications, while only 14.3% recommended dietary and lifestyle measures. The median duration for therapeutic education was 15 min (10, 20). In 96.2%, the education of the patient was done orally. 93.3% of rheumatologists inform their patients on how to manage a gout attack, and 96.2% on the measures of hygiene and diet has adopted. Our survey gives an insight into the elements that should be improved in the management of gout by the Moroccan rheumatologists. It highlights the need to standardize the management of gout, hence the importance of developing Moroccan recommendations on gout.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Rkain H, Benbrahim L, Moulay El Berkchi J, Aktaou S, Lazrak N, Faiz S, Ahid S, Abouqal R, Labzizi S, Ouzeddoun N, Oukerraj L, Hmamouchi I, Gragui B, Zohra Mchich-Alami F, Hajjaj Hassouni N (2019) Recommandations de la Société Marocaine de Rhumatologie (SMR) sur la goutte. Rev Marocaine de rhumatologie 48:3–18. https://doi.org/10.24398/A.349.2019

    Article  Google Scholar 

  2. Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11(11):649–662

    Article  Google Scholar 

  3. Moulay Berkchi J, Rkain H, Benbrahim L, Aktaou S, Lazrak N, Faiz S, Ahid S, Abouqal R, Labzizi S, Ouzeddoune N, Oukerraj L, Zohra Mchich-Alami F, Hajji S, Hajjaj-Hassouni N, Allali F (2019) Enquête sur la prise en charge de la goutte par les médecins généralistes Marocains. Rev Mar Rheum 48:48–53. https://doi.org/10.24398/A.330.2019

    Article  Google Scholar 

  4. Edwards NL (2010) Quality of care in patients with gout: why is management suboptimal and what can be done about it? Curr Rheumatol Rep 13:154–159

    Article  Google Scholar 

  5. Pascual E, Sivera F (2007) Why is gout so poorly managed? Ann Rheum Dis 66:1269–1270

    Article  Google Scholar 

  6. Doherty M, Jansen TL, Nuki G, Pascual E, Perez-Ruiz F, Punzi L et al (2012) Gout: why is this curable disease so seldom cured? Ann Rheum Dis 71:1765–1770

    Article  Google Scholar 

  7. Amorim RBC, Vargas-Santos AB, Pereira LR, Coutinho ESF, da RochaCastelar-Pinheiro G (2016) Gout treatment: survey of Brazilian rheumatology residents. Clin Rheumatol. https://doi.org/10.1007/s10067-017-3543-7

    Article  Google Scholar 

  8. Goossens J, Lancrenon S, Lanz S, Ea H-K, Lambert C, Guggenbuhl P, Saraux A, Delva C, Sahbane S, Liot´e F (2017) GOSPEL 3: management of gout by primary-care physicians and office-based rheumatologists in France in the early 21st century—comparison with 2006 EULAR recommendations. Joint Bone Spine. https://doi.org/10.1016/j.jbspin.2017.04.002

    Article  PubMed  Google Scholar 

  9. Sautner J, Gruber J, Herold M et al (2013) Austrian 3e-recommendations for diagnosis and management of gout. Wien Klin Wochenschr 126:79–89

    Article  Google Scholar 

  10. Sivera F, Andres M, Carmona L et al (2013) Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis 73:328–335

    Article  Google Scholar 

  11. Richette P, Doherty M, Pascual E et al (2016) Updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis2016-209707

    Article  PubMed  Google Scholar 

  12. Vargas-Santos AB, Castelar-Pinheiro Gda R, Coutinho ES, Schumacher HR Jr, Singh JA, Schlesinger N (2015) Adherence to the 2012 American College of Rheumatology (ACR) guidelines for management of gout: a survey of Brazilian rheumatologists. PLoS ONE 10:e0135805

    Article  Google Scholar 

  13. Perez-Ruiz F, Carmona L, Ye´ benes MJ et al (2011) An audit of the variability of diagnosis and management of gout in the rheumatology setting: the gout evaluation and management study. J Clin Rheumatol 2011(17):34955

    Google Scholar 

  14. Richette P, Flipo RN, Patrikos DK (2015) Characteristics and management of gout patients in Europe: data from a large cohort of patients. Eur Rev Med Pharmacol Sci 2015(19):630

    Google Scholar 

  15. Doherty M, Bardin T, Pascual E (2007) International survey on the diagnosis and management of gout. Ann Rheum Dis 66:1685–1686

    Article  CAS  Google Scholar 

  16. Reinders MK, Jansen TL (2008) Survey on management of gout among Dutch rheumatologists. Ann Rheum Dis 67:1049

    Article  CAS  Google Scholar 

  17. Schlesinger N, Moore DF, Sun JD, Schumacher HR Jr (2006) A survey of current evaluation and treatment of gout. J Rheumatol 33:2050–2052

    PubMed  Google Scholar 

  18. Silva L, Miguel ED, Peiteado D et al (2010) Compliance in gout patients. Acta Reumatol Port 35(5):466–474

    CAS  PubMed  Google Scholar 

  19. Yu KH, Wu YJJ (2006) Gout and hyperuricemia: recent advances and a systematic review. Formosan J Rheumatol 20:6–18

    Google Scholar 

  20. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH (2009) Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 61(2):225–232

    Article  CAS  Google Scholar 

  21. Abhishek A, Doherty M (2018) Education and non-pharmacological approaches for gout. Rheumatology (Oxford) 57(1):i51–i58

    Article  Google Scholar 

  22. Choi HK, Ford ES, Li C, Curhan G (2007) Prevalence of the metabolic syndrome in patients with gout: the third national health and nutrition examination survey. Arthritis Rheum 57(1):109–115

    Article  Google Scholar 

  23. Zhang S, Wang Y, Cheng J, Huangfu N, Zhao R, Xu Z, Zhang F, Zheng W, Zhang D (2019) Hyperuricemia and cardiovascular disease. Curr Pharm Des 25(6):700–709. https://doi.org/10.2174/1381612825666190408122557

    Article  CAS  PubMed  Google Scholar 

  24. Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T et al (2012) 2012 American college of rheumatology guidelines for management of gout Part 1: systematic non pharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 64(10):1431–1446

    Article  CAS  Google Scholar 

  25. Robinson PC, Dalbeth N, Donovan P (2018) The cost-effectiveness of biannual serum urate (SU) monitoring after reaching target in gout: a health economic analysis comparing SU monitoring. J Rheumatol 45(5):697–704

    Article  Google Scholar 

  26. Richette P, Doherty M, Pascual E et al (2020) 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis 79:31–38

    Article  Google Scholar 

  27. Chalès G (2018) How should we manage asymptomatic hyperuricemia? Joint Bone Spine. https://doi.org/10.1016/j.jbspin.2018.10.004

    Article  PubMed  Google Scholar 

  28. Bardin T, Richette P (2014) Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol 2014(26):186–191

    Article  Google Scholar 

  29. Cho SK, Chang Y, Kim I, Ryu S (2018) U-shaped association between serum uric acid level and risk of mortality: a cohort study. Arthritis Rheumatol 2018(70):1122–1132

    Article  Google Scholar 

  30. Paul BJ, Anoopkumar K, Krishnan V (2017) Asymptomatic hyperuricemia: is it time to intervene? Clin Rheumatol 36:2637–2644

    Article  Google Scholar 

  31. Rock KL, Kataoka H, Lai J-J (2013) Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol 9(1):13–23

    Article  CAS  Google Scholar 

  32. Stamp L, Dalbeth N (2017) Urate-lowering therapy for asymptomatic hyperuricaemia: a need for caution. Semin Arthritis Rheum 46(4):457–464

    Article  Google Scholar 

  33. Hui M, Carr A, Cameron S, Davenport G, Doherty M, Forrester H, Jenkins W, Jordan KM, Mallen CD, McDonald TM et al (2017) The British society for rheumatology guideline for the management of gout. Rheumatology 56(7):e1–e20. https://doi.org/10.1093/rheumatology/kex156

    Article  CAS  PubMed  Google Scholar 

  34. Rees F, Jenkins W, Doherty M (2013) Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study. Ann Rheum Dis 2013(72):826–830

    Article  Google Scholar 

  35. Day RO (2009) Adherence to urate-lowering therapy. South Med J 102(1):114–115

    Article  Google Scholar 

Download references

Acknowledgements

We are grateful to the Moroccan Society of Rheumatology for providing us with the data which we needed, to the Gout Committee members for their support, and to the rheumatologists whose participation made this survey possible.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Rheumatology B, El Ayachi Hospital, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University, Rabat, Morocco

    Jihad Moulay Berkchi, Hanan Rkain & Fadoua Allali

  2. Laboratory of Physiology, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University, Rabat, Morocco

    Hanan Rkain

  3. Day Clinic, Delegation of the Ministry of Health at the Rabat Prefecture, Rabat Regional Hospital, Rabat, Morocco

    Laila Benbrahim

  4. Private Rheumatology Clinic, Rabat, Morocco

    Souad Aktaou & Noufissa Lazrak

  5. Delegation of the Ministry of Health at the Prefecture of Casablanca, Casablanca, Morocco

    Souad Faiz

  6. Pharmacology and Toxicology Laboratory, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University, Rabat, Morocco

    Samir Ahid

  7. Faculty of Pharmacy, Mohammed VI University of Health Sciences, Casablanca, Morocco

    Samir Ahid

  8. Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco

    Redouane ABOUQAL & Ihsane Hmamouchi

  9. National Nutrition Program, Direction of Population, Ministry of Public Health, Rabat, Morocco

    Saloua Labzizi

  10. Department of Nephrology-Hemodialysis, CHU Ibn Sina, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University, Rabat, Morocco

    Naima Ouzeddoun

  11. Department of Cardiology B, Souissi Maternity, CHU Ibn Sina, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University, Rabat, Morocco

    Latifa Oukerraj

  12. International University of Rabat, Rabat, Morocco

    Najia Hajjaj-Hassouni

Authors
  1. Jihad Moulay Berkchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanan Rkain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laila Benbrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Souad Aktaou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Noufissa Lazrak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Souad Faiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Samir Ahid
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Redouane ABOUQAL
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Saloua Labzizi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Naima Ouzeddoun
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Latifa Oukerraj
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Ihsane Hmamouchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Najia Hajjaj-Hassouni
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Fadoua Allali
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jihad Moulay Berkchi.

Ethics declarations

Conflict of interest

The authors have declared no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moulay Berkchi, J., Rkain, H., Benbrahim, L. et al. Management of gout by Moroccan rheumatologists: a Moroccan Society for Rheumatology National Survey. Rheumatol Int 40, 1399–1408 (2020). https://doi.org/10.1007/s00296-020-04599-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-020-04599-0

Keywords

Search

Navigation